Risks
4 risks
Risk Intelligence
New bed ramp-up may pressure margins
View Risks →Apollo Hospitals Enterprise Limited — Q3 FY26
Apollo Hospitals delivered a strong Q3 FY26 with consolidated revenue of ₹6,477 crore (+17% YoY), EBITDA of ₹965 crore (+27% YoY), and PAT of ₹502 crore (+35% YoY).
bullish
high
Financial stats pending filing verification
2-Minute Summary
✦ AI-Generated from Full Transcript
Apollo Hospitals delivered a strong Q3 FY26 with consolidated revenue of ₹6,477 crore (+17% YoY), EBITDA of ₹965 crore (+27% YoY), and PAT of ₹502 crore (+35% YoY). Healthcare services revenue grew 14% to ₹3,183 crore, driven by 5% volume growth, 4% case mix, and 5% pricing. Hospital EBITDA margin expanded to 24.8% (+120bps YoY). Apollo HealthCo revenue rose 20% to ₹2,827 crore, with digital losses narrowing to ₹67 crore (cash loss ₹29 crore). AHLL EBITDA grew 39% to ₹48 crore with margins at 10.2%. Management guided for ~1,500 new beds over FY27-28, with ~750 operational in FY27, expecting ~₹150 crore start-up losses. The digital business cash break-even is pushed to Q1 FY27 due to insurance revenue recognition changes. Key risk: new bed ramp-up could pressure near-term margins if occupancy gains lag.
अपोलो हॉस्पिटल्स ने तीसरी तिमाही में शानदार प्रदर्शन किया। कंपनी की कुल कमाई ₹6,477 करोड़ रही, जो पिछले साल से 17% ज़्यादा है। मुनाफा ₹502 करोड़ (+35%) और परिचालन लाभ ₹965 करोड़ (+27%) रहा। अस्पताल सेवाओं की कमाई 14% बढ़कर ₹3,183 करोड़ हुई, जिसमें मरीज़ों की संख्या में 5%, इलाज के मिश्रण में 4% और कीमतों में 5% का योगदान रहा। डिजिटल कारोबार का घाटा घटकर ₹67 करोड़ रह गया। कंपनी अगले दो सालों में करीब 1,500 नए बिस्तर जोड़ेगी, जिसमें से 750 अगले साल तैयार होंगे। शुरुआती घाटा करीब ₹150 करोड़ रहेगा। डिजिटल कारोबार अगली तिमाही तक लाभ में आ जाएगा। जोखिम: नए बिस्तरों की संख्या बढ़ने से शुरुआती मुनाफ़े पर दबाव पड़ सकता है।
Risks4 trackedTranscriptfull text
Research workspace
Focused Modules
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
Group Occupancy
67%
+200bps YoY
Occupancy improved from 65% in Q3 FY25, driven by higher surgical volumes and case mix.
Average Revenue Per Patient (ARP)
₹1,80,917
+4.4% QoQ
ARP increased from ₹1,73,246 in Q2 FY26, reflecting higher clinical intensity and pricing.
Apollo 24/7 Platform GMV
₹525 crore
+28% YoY
GMV growth adjusted for GST and Amazon channel closure; pharmacy online grew 32%.
Digital Business Cash Loss
₹29 crore
-57% YoY
Lowest ever quarterly cash loss; insurance revenue deferral pushed break-even to Q1 FY27.
What Changed vs Last Quarter
NEW
New bed addition of ~1,500 over FY27-28
Approximately 750 beds to be operationalized in FY27 across Hyderabad, Kolkata, Bangalore, and Gurugram, with the balance in early FY28.
NEW
Digital business cash break-even by Q1 FY27
Cash EBITDA break-even for Apollo 24/7 delayed by one quarter due to insurance revenue recognition mismatch; otherwise on track.
NEW
Existing hospital margin expansion of ~100bps in FY27
Management expects to improve existing hospital EBITDA margins by about 100 basis points through asset utilization and cost initiatives.
UPDATED
Start-up losses of ~₹150 crore in FY27
Management expects total pre-opening and ramp-up losses of around ₹150 crore for new hospitals in the next fiscal year.
DROPPED
Healthcare services organic growth to return to 13%
Management expects healthcare services revenue growth to revert to 13% as Bangladesh patients return and new markets are explored.
DROPPED
Apollo 24/7 break-even by Q4 FY26
The digital platform is on course to achieve break-even by end of this fiscal year, though insurance investments may cause a slight delay.
DROPPED
HealthCo margin target of 7% by Q4 FY27
Apollo HealthCo aims for a revenue run rate of ₹25,000 crore and 7% EBITDA margin by Q4 FY27, with current H1 margin at 4.4%.
NEW RISK
New bed ramp-up may pressure margins
Start-up losses of ~₹150 crore from new hospitals could drag consolidated margins if occupancy ramps slower than expected.
NEW RISK
Insurance contract renewal delays
Some insurance contracts faced delays in renewal, impacting payor mix; management noted delays but expects resolution.
NEW RISK
Digital business revenue recognition changes
GST changes and insurance revenue deferral caused a ~₹70 crore mismatch, pushing break-even; sustainability of growth needs monitoring.
NEW RISK
Talent retention amid industry expansion
Competitors are poaching senior doctors; management downplayed risk but recent high-profile departures warrant attention.
RISK GONE
Occupancy below 70% and volume growth concerns
Occupancy declined to 69% from 73% last year, with medical admissions dropping 6% due to seasonality. Management targets 70% but faces structural challenges from shorter ALOS.
RISK GONE
Margin dilution from new hospital ramp-up
Pre-opening costs of ~₹150 crore EBITDA losses from six new hospitals could pressure consolidated margins, especially in H1 FY27.
RISK GONE
Competitive pressure in diagnostics segment
Specialty care within AHL faces serious competition in diagnostics, impacting growth. Management acknowledged headwinds but provided limited mitigation details.
RISK GONE
CGHS rate hike has limited financial impact
Despite a significant CGHS rate hike, management noted that government business still offers a 65% discount to private tariffs, limiting margin benefit.
Fast read
Guidance and risk preview
Approximately 750 beds to be operationalized in FY27 across Hyderabad, Kolkata, Bangalore, and Gurugram, with the balance in early FY28.
Start-up losses of ~₹150 crore from new hospitals could drag consolidated margins if occupancy ramps slower than expected.
View Risks →